Danish drugmaker Lundbeck will buy La Jolla, CA-based Longboard Pharmaceuticals for $2.6 billion in cash, the companies said ...

Transgene’s therapeutic cancer vaccine candidate has failed a mid-stage test in certain HPV-driven cancers, sending its ...

Novo Holdings is set to buy one less facility from Catalent as the manufacturer has sold a facility in New Jersey to a ...

Seven years ago, Daniel Ives believed that he was on the cusp of solving aging. He wanted to continue working on a discovery ...

The global cell and gene therapy (CGT) industry is poised for remarkable growth, driven by significant advances in life ...

The FDA said it will reconsider the removal of Eli Lilly’s GLP-1 drug tirzepatide from its official shortage list, after a ...

Whew. Pfizer — after a week in which it began a showdown with an activist investor, was betrayed by and then reunited with ...

Generics giant Teva Pharmaceuticals will pay $450 million over six years to settle two allegations that the company violated ...

Sanofi has chosen US private equity firm Clayton, Dubilier & Rice to advance acquisition talks for its consumer health unit, ...

A small venture capital firm that backs up-and-coming scientists plans to raise a $35 million second fund, three years after ...

This week, Stealth BioTherapeutics CEO Reenie McCarthy faced a seemingly insurmountable roadblock with the company's drug for ...

Valneva is eyeing a 2027 launch for its Pfizer-partnered Lyme disease vaccine, CEO Thomas Lingelbach said Thursday during the ...